Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBNL1 | Q9NR56 | 1/20 | 0.76 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.72 |
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | GSR | P00390 | 7/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23904881 | 1.00 | MBNL1 (0.76) | MBNL1ADORA2AMEN1KMT2ATDP1 | |
| SCHEMBL23904131 | 0.99 | MBNL1 (0.77) | MBNL1ADORA2AMEN1KMT2ATDP1 | |
| SCHEMBL23795497 | 0.95 | MBNL1 (0.75) | MBNL1ADORA2AMEN1KMT2ATDP1 | |
| SCHEMBL6895389 | 0.94 | MBNL1 (0.67) | MBNL1ADORA2AMEN1KMT2ATDP1 | |
| SCHEMBL20087077 | 0.94 | MBNL1 (0.80) | MBNL1ADORA2AMEN1KMT2ATDP1 | |
| SCHEMBL20087027 | 0.94 | MBNL1 (0.80) | MBNL1ADORA2AMEN1KMT2ATDP1 | |
| SCHEMBL20087053 | 0.94 | MBNL1 (0.80) | MBNL1ADORA2AMEN1KMT2ATDP1 | |
| SCHEMBL7869225 | 0.93 | MBNL1 (0.81) | MBNL1ADORA2AMEN1KMT2ATDP1 | |
| SCHEMBL8902680 | 0.93 | MBNL1 (0.67) | MBNL1ADORA2AMEN1KMT2ATDP1 | |
| SCHEMBL27739751 | 0.93 | ADORA2A (0.74) | MBNL1ADORA2AMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021202669-A2 | NUCLEOSIDE AND NUCLEOTIDE CONJUGATE COMPOUNDS AND USES THEREOF | REYOUNG CORPORATION (US) | 2021-10-07 | — | — | WO | disclosed |